Although the majority of the studies reported here were performed using ALL-5 cells, ALL-2 cells showed a highly similar profile of caspase-3 activation after VCR treatment, with low levels in G1 phase cells and much higher levels in G2/M phase cells (Fig. S2). This evidence concerns the gene CASP3 and acute lymphoblastic leukemia.